Summary#
HB 1153 would amend the Texas Insurance Code; it would not create a separate law. For certain health benefit plans, it would bar cost-sharing for coverage of screening mammograms, diagnostic imaging and supplemental breast examinations. Its stated subject is coverage for those examinations; the bill does not promise any particular health outcome.
- “Diagnostic imaging” would include medically necessary and appropriate breast examinations under National Comprehensive Cancer Network guidelines. The definition covers several imaging types and examinations for detected or previously seen abnormalities, follow-up of an abnormality considered probably benign, or a person’s history of breast cancer or dense breast tissue.
- “Supplemental breast examination” would include medically necessary and appropriate imaging used to screen when no abnormality has been seen or suspected by a physician, based on personal or family history or other risk factors, including heterogeneously or extremely dense breasts.
- A covered plan could not impose a deductible, copayment, coinsurance or similar out-of-pocket cost on coverage for the three named types of examination.
- The bill applies to plans delivered, issued or renewed on or after January 1, 2028. It would take effect September 1, 2027. If a state agency finds a federal waiver or authorization is needed, the agency must request it and may delay implementation until it is granted.
What it means for you#
- Patients: If your plan is covered by the amended section and provides coverage for one of these examinations, it could not charge you cost-sharing for that coverage. The supplied text does not show which plans must provide the coverage in the first place.
- Health benefit plans: Plans covered by the section would have to follow the no-cost-sharing rule for applicable coverage starting with plans issued, delivered or renewed on or after January 1, 2028.
- State agencies: If an agency determines a federal waiver or authorization is necessary, it must request one; it may wait to implement the affected provision until approval.
- General public: This is an insurance-coverage change, not a new screening service or a rule requiring patients to get an examination. HB 1153 is introduced and is not law.
Money#
No cost estimate is provided in the supplied material.
- Patients would not pay cost-sharing for the specified coverage under plans subject to the rule.
- The bill does not provide an estimate of plan costs, effects on premiums, staffing costs for state agencies or public spending.
What is unclear#
- The supplied material does not include the rest of Insurance Code section 1356.005 or the parent Act, so the exact plans covered and existing coverage requirements cannot be verified.
- The bill does not explain how the National Comprehensive Cancer Network guidelines would be applied or how disputes about medical necessity and appropriateness would be handled.
- It does not set out an application, review, appeal, reporting or enforcement process for this change.
- It is unclear which provisions, if any, would be delayed while a federal waiver or authorization is pending.
Case for#
- A possible argument for the bill is that cost-sharing can be removed for the listed breast examinations, reducing patients’ direct out-of-pocket costs when they receive covered care.
- The definitions expressly include follow-up imaging for certain abnormalities and screening based on risk factors, including dense breast tissue. That could make the no-cost-sharing rule apply to more than routine screening mammograms.
- Tying the definitions to medical-necessity and appropriateness guidelines could help set clinical limits on which examinations qualify.
Case against#
- The bill does not show which plans must cover these examinations, so the practical reach of the no-cost-sharing rule is uncertain.
- It does not explain how medical necessity, appropriateness or the cited guidelines would be applied or challenged.
- A possible trade-off is that plans could face higher costs when patients no longer pay cost-sharing. The bill provides no estimate of those costs or whether they could affect premiums.